Announcements Trials
Browse Landscape

Status

Completed 4

Sponsor Class

OTHER 19INDUSTRY 4

Study Type

Interventional 793Observational 4Expanded_access 1

Sponsor

Cancer Type

Gastrointestinal 2Tumor-Agnostic 1Thoracic 1

Conditions

Pancreatic Neoplasms 2Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Blood Specimen Collection 31Sorafenib 29Nivolumab 29Bevacizumab 26Data Collection 24Observation 23palbociclib 22Sunitinib 22radium Ra 223 dichloride 20enzalutamide 18Rituximab 18Ipilimumab 16regorafenib 15Drug Therapy 15Trastuzumab 14Docetaxel 14ribociclib 12exemestane 12atezolizumab 12Standard of Care 12darolutamide 11apalutamide 11Leuprolide 11Capecitabine 11Afatinib 11Bortezomib 10Anastrozole 10trastuzumab deruxtecan 9pembrolizumab 9avelumab 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
INDUSTRY × Observational × Gemcitabine × Clear all
NCT07141563 2026-01-07

A Study Describing Real-World Effectiveness of Nivolumab + Chemotherapy in Neoadjuvant NSCLC

Bristol-Myers Squibb

Completed
70 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02555813 2020-10-19

Treatment of Pancreatic Cancer With Abraxane

Celgene

Completed
317 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT01782690 2018-07-23

An Observational Study of Erlotinib Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer

Hoffmann-La Roche

Completed
338 enrolled 18 charts
Gastrointestinal

Pancreatic Neoplasms

NCT01251653 2016-05-30

A Phase I Dose Escalation Trial of Afatinib Plus Gemcitabine or Plus Docetaxel

Boehringer Ingelheim

Completed
94 enrolled 33 charts
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡